<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p25" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_25{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_25{left:341px;bottom:30px;}
#t3_25{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_25{left:377px;bottom:30px;}
#t5_25{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_25{left:540px;bottom:30px;}
#t7_25{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_25{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_25{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_25{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_25{left:285px;bottom:827px;letter-spacing:-0.26px;}
#tc_25{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_25{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_25{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_25{left:266px;bottom:778px;letter-spacing:0.34px;word-spacing:-0.17px;}
#tg_25{left:36px;bottom:748px;letter-spacing:-0.09px;}
#th_25{left:47px;bottom:729px;letter-spacing:-0.09px;}
#ti_25{left:47px;bottom:711px;letter-spacing:-0.09px;}
#tj_25{left:36px;bottom:686px;letter-spacing:-0.1px;}
#tk_25{left:47px;bottom:667px;letter-spacing:-0.12px;word-spacing:0.02px;}
#tl_25{left:512px;bottom:675px;}
#tm_25{left:36px;bottom:642px;}
#tn_25{left:47px;bottom:642px;letter-spacing:-0.1px;word-spacing:0.01px;}
#to_25{left:36px;bottom:617px;}
#tp_25{left:47px;bottom:617px;letter-spacing:-0.11px;word-spacing:0.02px;}
#tq_25{left:684px;bottom:624px;letter-spacing:-0.12px;}
#tr_25{left:36px;bottom:592px;}
#ts_25{left:47px;bottom:592px;letter-spacing:-0.1px;}
#tt_25{left:652px;bottom:599px;letter-spacing:-0.09px;}
#tu_25{left:36px;bottom:567px;letter-spacing:-0.12px;word-spacing:0.03px;}
#tv_25{left:47px;bottom:548px;letter-spacing:-0.09px;}
#tw_25{left:47px;bottom:530px;letter-spacing:-0.1px;}
#tx_25{left:36px;bottom:505px;letter-spacing:-0.09px;word-spacing:-0.06px;}
#ty_25{left:673px;bottom:512px;}
#tz_25{left:36px;bottom:479px;}
#t10_25{left:47px;bottom:479px;letter-spacing:-0.1px;}
#t11_25{left:1107px;bottom:487px;}
#t12_25{left:1105px;bottom:28px;letter-spacing:0.34px;}
#t13_25{left:35px;bottom:288px;}
#t14_25{left:45px;bottom:282px;letter-spacing:0.1px;word-spacing:0.01px;}
#t15_25{left:44px;bottom:265px;letter-spacing:0.12px;word-spacing:-0.1px;}
#t16_25{left:44px;bottom:248px;letter-spacing:0.12px;}
#t17_25{left:35px;bottom:237px;}
#t18_25{left:45px;bottom:231px;letter-spacing:0.09px;word-spacing:-0.05px;}
#t19_25{left:44px;bottom:214px;letter-spacing:0.11px;word-spacing:0.01px;}
#t1a_25{left:44px;bottom:198px;letter-spacing:0.03px;word-spacing:0.1px;}
#t1b_25{left:35px;bottom:187px;}
#t1c_25{left:45px;bottom:181px;letter-spacing:0.12px;word-spacing:-0.07px;}
#t1d_25{left:44px;bottom:164px;letter-spacing:0.13px;}
#t1e_25{left:44px;bottom:147px;letter-spacing:0.11px;word-spacing:0.01px;}
#t1f_25{left:35px;bottom:136px;}
#t1g_25{left:45px;bottom:130px;letter-spacing:0.12px;word-spacing:-0.06px;}
#t1h_25{left:44px;bottom:114px;letter-spacing:0.11px;word-spacing:0.01px;}
#t1i_25{left:667px;bottom:249px;}
#t1j_25{left:677px;bottom:243px;letter-spacing:0.13px;word-spacing:-0.08px;}
#t1k_25{left:675px;bottom:226px;letter-spacing:0.13px;word-spacing:-0.28px;}
#t1l_25{left:667px;bottom:215px;}
#t1m_25{left:677px;bottom:209px;letter-spacing:0.12px;word-spacing:-0.02px;}
#t1n_25{left:675px;bottom:192px;letter-spacing:0.12px;}
#t1o_25{left:675px;bottom:176px;letter-spacing:0.12px;}
#t1p_25{left:675px;bottom:159px;letter-spacing:0.06px;word-spacing:0.07px;}
#t1q_25{left:667px;bottom:148px;}
#t1r_25{left:677px;bottom:142px;letter-spacing:0.11px;word-spacing:0.01px;}
#t1s_25{left:675px;bottom:125px;letter-spacing:0.13px;word-spacing:-0.08px;}
#t1t_25{left:675px;bottom:108px;letter-spacing:0.13px;word-spacing:-0.17px;}
#t1u_25{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_25{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_25{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_25{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_25{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_25{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_25{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_25{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.s7_25{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s8_25{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s9_25{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sa_25{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sb_25{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts25" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg25Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg25" style="-webkit-user-select: none;"><object width="1210" height="935" data="25/25.svg" type="image/svg+xml" id="pdf25" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_25" class="t s0_25">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_25" class="t s1_25">® </span>
<span id="t3_25" class="t s0_25">(NCCN </span>
<span id="t4_25" class="t s1_25">® </span>
<span id="t5_25" class="t s0_25">), All rights reserved. NCCN Guidelines </span>
<span id="t6_25" class="t s1_25">® </span>
<span id="t7_25" class="t s0_25">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_25" class="t s2_25">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_25" class="t s2_25">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_25" class="t s3_25">NCCN Guidelines Version 4.2024 </span>
<span id="tb_25" class="t s3_25">Cancer of the Oropharynx </span>
<span id="tc_25" class="t s4_25">NCCN Guidelines Index </span>
<span id="td_25" class="t s4_25">Table of Contents </span>
<span id="te_25" class="t s4_25">Discussion </span>
<span id="tf_25" class="t s5_25">PRINCIPLES OF P16 TESTING FOR HPV-MEDIATED OROPHARYNGEAL CANCER </span>
<span id="tg_25" class="t s5_25">• P16 expression correlates with HPV status in geographic regions where HPV is etiologically responsible for a high proportion of cancers. </span>
<span id="th_25" class="t s6_25" data-mappings='[[3,"fi"]]'>Conﬁrmatory HPV direct testing is recommended, especially for clinical trials. Clinical centers are recommended to ascertain concordance </span>
<span id="ti_25" class="t s5_25">rate of p16 and direct HPV testing, as this may vary by region, if considering use of p16 IHC alone as a surrogate. </span>
<span id="tj_25" class="t s5_25">• Distinguishing p16+ patients by HPV tumor status informs prognosis. Patients with p16+ and HPV+ tumors have an improved prognosis </span>
<span id="tk_25" class="t s5_25">compared to patients with p16+ and HPV-negative tumors. </span>
<span id="tl_25" class="t s7_25">1 </span>
<span id="tm_25" class="t s5_25">• </span><span id="tn_25" class="t s6_25" data-mappings='[[14,"fi"]]'>Direct HPV conﬁrmatory tests include polymerase chain reaction (PCR) and RNA in situ hybridization (ISH). </span>
<span id="to_25" class="t s5_25">• </span><span id="tp_25" class="t s6_25" data-mappings='[[73,"fi"]]'>PCR may provide additional sensitivity while ISH provides increased speciﬁcity. </span>
<span id="tq_25" class="t s7_25">2-5 </span>
<span id="tr_25" class="t s5_25">• </span><span id="ts_25" class="t s6_25" data-mappings='[[2,"ffi"]]'>Suﬃcient pathologic material for HPV testing can be obtained through FNA. </span>
<span id="tt_25" class="t s7_25">5,6 </span>
<span id="tu_25" class="t s5_25">• A small proportion of tumors at non-oropharyngeal sites (eg, paranasal sinus, oral cavity, larynx) are HPV-related. However, given the small </span>
<span id="tv_25" class="t s6_25" data-mappings='[[73,"fi"]]'>proportion and lack of consistent evidence in support of prognostic signiﬁcance, routine HPV testing or p16 testing of non-oropharyngeal </span>
<span id="tw_25" class="t s5_25">cancers is not recommended. </span>
<span id="tx_25" class="t s5_25">• Guidelines for testing are available from the College of American Pathologists. </span>
<span id="ty_25" class="t s7_25">7 </span>
<span id="tz_25" class="t s5_25">• </span><span id="t10_25" class="t s6_25" data-mappings='[[28,"ff"]]'>When using p16, the 70% cutoﬀ with nuclear and cytoplasmic expression with at least moderate to strong intensity is recommended. </span>
<span id="t11_25" class="t s7_25">7 </span>
<span id="t12_25" class="t s5_25">ORPH-B </span>
<span id="t13_25" class="t s8_25">1 </span>
<span id="t14_25" class="t s9_25">Mehanna H, Taberna M, von Buchwald C, et al. Prognostic implications of p16 and HPV </span>
<span id="t15_25" class="t s9_25">discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): A multicentre, multinational, </span>
<span id="t16_25" class="t s9_25">individual patient data analysis. Lancet Oncol. 2023;24:239-251. </span>
<span id="t17_25" class="t s8_25">2 </span>
<span id="t18_25" class="t s9_25">Cantley RL, Gabrielli E, Montebelli F, et al. Ancillary studies in determining human </span>
<span id="t19_25" class="t s9_25">papillomavirus status of squamous cell carcinoma of the oropharynx: a review. Patholog </span>
<span id="t1a_25" class="t s9_25">Res Int 2011;2011:138469. </span>
<span id="t1b_25" class="t s8_25">3 </span>
<span id="t1c_25" class="t sa_25">Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and </span>
<span id="t1d_25" class="t s9_25">p16 immunohistochemistry in the detection of human papillomavirus-associated head and </span>
<span id="t1e_25" class="t s9_25">neck cancer based on a prospective clinical experience. Cancer 2010;116:2166-2173. </span>
<span id="t1f_25" class="t s8_25">4 </span>
<span id="t1g_25" class="t s9_25">Thavaraj S, Stokes A, Guerra E, et al. Evaluation of human papillomavirus testing for </span>
<span id="t1h_25" class="t s9_25">squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 2011;64:308-312. </span>
<span id="t1i_25" class="t s8_25">5 </span>
<span id="t1j_25" class="t s9_25">Snow AN, Laudadio J. Human papillomavirus detection in head and neck </span>
<span id="t1k_25" class="t s9_25">squamous cell carcinomas. Adv Anat Pathol 2010;17:394-403. </span>
<span id="t1l_25" class="t s8_25">6 </span>
<span id="t1m_25" class="t s9_25">Begum S, Gillison ML, Nicol TL, Westra WH. Detection of human </span>
<span id="t1n_25" class="t s9_25">papillomavirus-16 in fine-needle aspirates to determine tumor origin in </span>
<span id="t1o_25" class="t s9_25">patients with metastatic squamous cell carcinoma of the head and neck. </span>
<span id="t1p_25" class="t s9_25">Clin Cancer Res 2007;13:1186-1191. </span>
<span id="t1q_25" class="t s8_25">7 </span>
<span id="t1r_25" class="t s9_25">Lewis JS, Jr., Beadle B, Bishop JA, et al. Human papillomavirus testing </span>
<span id="t1s_25" class="t s9_25">in head and neck carcinomas: Guideline from the College of American </span>
<span id="t1t_25" class="t s9_25">Pathologists. Arch Pathol Lab Med 2018;142:559-597. </span>
<span id="t1u_25" class="t sb_25">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
